Mental Health

A new survey shows 77% of Americans embrace AI in behavioral health, but only with strict transparency, strong safeguards, and a doctor in the loop.

A new cancer care company has tapped titans of medicine, policy, and patient advocacy to guide its mission of transforming treatment from the clinic to the home.

New Directions Mental Health adds cutting-edge Spravato and TMS therapies, expanding access for Pennsylvanians with treatment-resistant depression.

Immigration Minister Diab is set to announce major changes to Canada's skilled worker program, targeting key labor shortages and reshaping the path to PR.

Chamber of Mothers and SmartyPants Vitamins launch a national program to rebuild community support for mothers facing unprecedented levels of isolation.

A new podcast from Understood.org and the Davos Neurodiversity Summit elevates neurodivergent voices, turning a global economic forum into a stage for inclusion.

Pioneering surgeon Dr. Gopal H. Badlani receives a top honor for his decades of work building sustainable urological care in underserved nations.

A new book introduces a controversial but promising treatment that reframes trauma as a physical injury, offering a biological 'reset' for the nervous system.

A new collaborative is launching major health services, from maternal care to mental health, to address deep-seated disparities on Chicago's Far Southside.

Neurotech leader BrainsWay adjusts its share structure in a move to enhance liquidity, clarify valuation, and attract a broader base of global investors.

NRx Pharmaceuticals gets a green light from the FDA to seek broader approval for its ketamine drug, NRX-100, using a novel real-world evidence approach.

With a key depression drug nearing Phase 3 and more data imminent, AtaiBeckley is set to make its case to Wall Street at three major March conferences.

Landmark Phase 3 trial results show psilocybin offers rapid, lasting relief for severe depression, pushing psychedelic medicine closer to the mainstream.

A new health tech company has assembled a star-studded scientific board to back its AI-powered dementia prevention app. But can it deliver on its promise?

With a novel glutamate-targeting drug and a €38M cash injection, Newron aims to transform care for treatment-resistant schizophrenia.

A lawsuit claims a specialized pediatric daycare failed to protect a vulnerable child, leading to unexplained injuries and a state investigation.

With 15+ years on the front lines, new DOMAC leader Monica Trimble plans to elevate the role of dental office managers through national certification.

A U.S. firm enters Puerto Rico's embattled water market, promising advanced filtration for hospitals and hotels plagued by infrastructure woes.

The firm reports a $195M cash reserve but a wider net loss as it nears crucial data readouts for its novel depression and anxiety drug candidates.

A federal agency's safety warning has sparked a high-stakes legal fight, pitting a small business against regulators in a battle over science and survival.